EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases

Qi Tian iD, Yanji Tong iD, Fang Yu, Xiaoming Hu iD

CNS Neuroscience & Therapeutics · 2026-10 · 32 (10)

DOI: 10.1002/cns.71118 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 06.10.2026. Verfasst von Qi Tian und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Platelet Factor 4. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NINDS NIH HHS, U.S. Department of Veterans Affairs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

As population aging accelerates worldwide, the prevalence and burden of neurodegenerative diseases (NDs) continue to rise, underscoring the urgent need to identify key molecular mechanisms driving disease progression and novel therapeutic targets. Chronic neuroinflammation is a hallmark of multiple NDs, including Alzheimer's disease and Parkinson's disease. Platelet factor 4 (PF4) is a chemokine primarily released by activated platelets and has traditionally been investigated for its roles in hemostasis, thrombosis, and peripheral inflammation.

Results

Growing evidence has implicated PF4 in the pathogenesis of NDs. Altered PF4 expression has been observed across multiple NDs. As a central player at the intersection of the nervous, immune, and vascular systems, PF4 modulates inflammation, vascular homeostasis, and neuronal survival, all of which are critical in the pathogenesis of NDs. Dissecting the cell‐type specific and temporally dynamic roles of PF4 across diverse disease contexts is essential for elucidating its contribution to neurodegenerative processes and disease progression.

Conclusion

This review highlights PF4 as a potential mechanistic mediator in NDs and discusses its promise as both a biomarker and a therapeutic target. Further elucidation of PF4 signaling pathways may provide new insights into disease mechanisms and uncover novel opportunities for targeted interventions in NDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesPlatelet Factor 4HumansAnimalsSignal Transduction

Stichwörter der Autor:innen

CXCR3 signalingimmune modulationneurodegenerative diseasesneuroprotectionplatelet factor 4

Substanzen

Platelet Factor 4

Autor:innen und Institutionen

  • Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Geriatric Research, Education and Clinical Center, Veterans Affairs Pittsburgh Health Care System, Pittsburgh, Pennsylvania, USA.
  • Department of Neurology, Westchester Medical Center New York Medical College, Valhalla, New York, USA.

ORCID-Profile: Qi Tian, Yanji Tong, Xiaoming Hu

Förderung

  • NIH HHS
  • NINDS NIH HHS
  • U.S. Department of Veterans Affairs
  • BLRD VA
  • National Institutes of Health

Zitieren

APA

Tian, Q., Tong, Y., Yu, F., & Hu, X. (2026). Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases. CNS Neuroscience & Therapeutics, 32(10). https://doi.org/10.1002/cns.71118

Vancouver

Tian Q, Tong Y, Yu F, Hu X. Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases. CNS Neuroscience & Therapeutics. 2026;32(10). doi:10.1002/cns.71118

BibTeX
@article{Tian2026,
  author = {Tian, Qi and Tong, Yanji and Yu, Fang and Hu, Xiaoming},
  title = {Insights Into the Role of Platelet Factor 4 in Neurodegenerative Diseases},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {10},
  doi = {10.1002/cns.71118}
}
Kostenlos starten →